NPM1 and acute myeloid leukemia: In a patient with NPM1-mutated AML in molecular relapse after allogeneic HSCT, preemptive donor lymphocyte infusion (DLI) induced polyspecific CD8+ T-cell responses directed also to #1 and #3 NPM1-mutated peptides, which contributed to molecular CR [22].